{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:07Z","timestamp":1786120207158,"version":"build-2736575974"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/yco.0b013e328350360e","type":"journal-article","created":{"date-parts":[[2012,1,14]],"date-time":"2012-01-14T04:27:46Z","timestamp":1326515266000},"page":"89-95","source":"Crossref","is-referenced-by-count":63,"title":["Hormones and schizophrenia"],"prefix":"10.1097","volume":"25","author":[{"given":"Jayashri","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmy","family":"Gavrilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210206","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/7854_2010_100","article-title":"Estrogens and gonadal function in schizophrenia and related psychoses.","volume":"8","author":"Riecher-Rossler","year":"2011","journal-title":"Curr Top Behav Neurosci"},{"key":"R3-5-20210206","first-page":"323","article-title":"Schizophrenia and oestrogens: is there an association Eur Arch Psychiatry Clin","volume":"242","author":"Riecher-Rossler","year":"1993","journal-title":"Neurosci"},{"key":"R4-5-20210206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/00048679709073798","article-title":"Women and schizophrenia: a review.","volume":"31","author":"Kulkarni","year":"1997","journal-title":"Aust N Z J Psychiatry"},{"key":"R5-5-20210206","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1176\/ajp.154.12.1641","article-title":"Psychopathology in women and men: focus on female hormones.","volume":"154","author":"Seeman","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"R6-5-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia.","volume":"28","author":"Hafner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 4","key":"R7-5-20210206","first-page":"S37","article-title":"Oestrogen: a new treatment approach for schizophrenia Med J","volume":"190","author":"Kulkarni","year":"2009","journal-title":"Aust"},{"key":"R8-5-20210206","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/13697130400012262","article-title":"Hormones and depression in women.","volume":"7","author":"Studd","year":"2004","journal-title":"Climacteric"},{"key":"R9-5-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/09540261.2010.515205","article-title":"Sex differences in schizophrenia.","volume":"22","author":"Abel","year":"2010","journal-title":"Int Rev Psychiatry"},{"key":"R11-5-20210206","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00048670701732699","article-title":"Do women express and experience psychosis differently from men Epidemiological evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders.","volume":"42","author":"Morgan","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"R12-5-20210206","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.07.002","article-title":"Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis.","volume":"114","author":"Cotton","year":"2009","journal-title":"Schizophr Res"},{"key":"R13-5-20210206","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00737-009-0117-y","article-title":"Puerperal psychosis.","volume":"13","author":"Boyce","year":"2010","journal-title":"Arch Womens Ment Health"},{"key":"R14-5-20210206","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S0033291707000578","article-title":"Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia.","volume":"37","author":"Bergemann","year":"2007","journal-title":"Psychol Med"},{"key":"R15-5-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2010.09.014","article-title":"Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.","volume":"124","author":"Rubin","year":"2010","journal-title":"Schizophr Res"},{"key":"R16-5-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02088099","article-title":"Estrogen control of central neurotransmission: effect on mood, mental state, and memory.","volume":"16","author":"Fink","year":"1996","journal-title":"Cell Mol Neurobiol"},{"key":"R17-5-20210206","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1874467210902030215","article-title":"Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders.","volume":"2","author":"Hughes","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"R18-5-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0083-6729(10)82017-5","article-title":"Estrogen in the limbic system.","volume":"82","author":"ter Horst","year":"2010","journal-title":"Vitam Horm"},{"key":"R19-5-20210206","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yhbeh.2009.06.001","article-title":"Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection.","volume":"57","author":"Cosimo Melcangi","year":"2010","journal-title":"Horm Behav"},{"key":"R20-5-20210206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotoninglutamate receptor complex implicated in psychosis.","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"R21-5-20210206","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.","volume":"16","author":"Sanchez","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"R22-5-20210206","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"R23-5-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/187152409789630398","article-title":"Hormones in the mentally disturbed brain: steroids and peptides in the development and treatment of psychopathology.","volume":"9","author":"Taylor","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"R24-5-20210206","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2009.12.093","article-title":"The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study.","volume":"1321","author":"Chavez","year":"2010","journal-title":"Brain Res"},{"key":"R25-5-20210206","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FBP.0b013e32833da5c3","article-title":"The rapid effects of estrogen: a mini-review.","volume":"21","author":"Lokuge","year":"2010","journal-title":"Behav Pharmacol"},{"key":"R26-5-20210206","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.","volume":"32","author":"Bubenikova-Valesova","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"R27-5-20210206","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cne.20148","article-title":"Estrogen modulates synaptic N-methyl-D-aspartate receptor subunit distribution in the aged hippocampus.","volume":"474","author":"Adams","year":"2004","journal-title":"J Comp Neurol"},{"key":"R28-5-20210206","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.109.162123","article-title":"Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: Involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.","volume":"333","author":"Gogos","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-5-20210206","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/npp.2010.28","article-title":"Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17-estradiol: an animal model of menopausal psychosis","volume":"35","author":"Arad","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"R31-5-20210206","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2010.89","article-title":"Sex-dependent antipsychotic capacity of 17-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.","volume":"35","author":"Arad","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"R32-5-20210206","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1440-1789.2007.00798.x","article-title":"Neuropathology of schizophrenia: a mini review.","volume":"27","author":"Iritani","year":"2007","journal-title":"Neuropathology"},{"key":"R33-5-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","article-title":"A review of MRI findings in schizophrenia.","volume":"49","author":"Shenton","year":"2001","journal-title":"Schizophr Res"},{"key":"R34-5-20210206","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/YCO.0b013e32832a1353","article-title":"Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder.","volume":"22","author":"Fornito","year":"2009","journal-title":"Curr Opin Psychiatry"},{"key":"R35-5-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0193-953X(03)00105-9","article-title":"Review of cognition and brain structure in schizophrenia: profiles, longitudinal course, and effects of treatment.","volume":"27","author":"Flashman","year":"2004","journal-title":"Psychiatr Clin North Am"},{"key":"R36-5-20210206","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/JME-10-0122","article-title":"Selective estrogen receptor modulators as brain therapeutic agents.","volume":"46","author":"Arevalo","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"R37-5-20210206","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbagen.2009.10.002","article-title":"Actions of estrogens on glial cells: implications for neuroprotection.","volume":"1800","author":"Arevalo","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R38-5-20210206","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neuroscience.2010.08.019","article-title":"Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity.","volume":"170","author":"Bryant","year":"2010","journal-title":"Neuroscience"},{"key":"R39-5-20210206","doi-asserted-by":"crossref","first-page":"e9851","DOI":"10.1371\/journal.pone.0009851","article-title":"Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS One"},{"key":"R40-5-20210206","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/jcbfm.2010.181","article-title":"Estrogen enhances neurogenesis and behavioral recovery after stroke.","volume":"31","author":"Li","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"R41-5-20210206","first-page":"127","article-title":"Neuroprotection of sex steroids.","volume":"35","author":"Liu","year":"2010","journal-title":"Minerva Endocrinol"},{"key":"R42-5-20210206","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/jcbfm.2009.258","article-title":"Neuronal estrogen receptor- mediates neuroprotection by 17-estradiol.","volume":"30","author":"Elzer","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"R43-5-20210206","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbagen.2009.11.013","article-title":"Mitochondrial mechanisms of estrogen neuroprotection.","volume":"1800","author":"Simpkins","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R44-5-20210206","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s11064-008-9865-8","article-title":"Mitochondrial dysfunction and psychiatric disorders.","volume":"34","author":"Rezin","year":"2009","journal-title":"Neurochem Res"},{"key":"R45-5-20210206","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psyneuen.2004.05.010","article-title":"Sex hormones in psychotic men.","volume":"30","author":"Huber","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"R46-5-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2004.06.013","article-title":"Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.","volume":"73","author":"Bergemann","year":"2005","journal-title":"Schizophr Res"},{"key":"R48-5-20210206","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archpsyc.65.8.955","article-title":"Estrogen in severe mental illness: a potential new treatment approach.","volume":"65","author":"Kulkarni","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R49-5-20210206","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0278-5846(03)00161-1","article-title":"Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.","volume":"27","author":"Akhondzadeh","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R50-5-20210206","first-page":"278","article-title":"Estrogens and men with schizophrenia: is there a case for adjunctive therapy Schizophr","volume":"125","author":"Kulkarni","year":"2011","journal-title":"Res"},{"key":"R51-5-20210206","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.psyneuen.2010.01.014","article-title":"Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.","volume":"35","author":"Kulkarni","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"R52-5-20210206","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/schbul\/sbm138","article-title":"Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.","volume":"34","author":"Bergemann","year":"2008","journal-title":"Schizophr Bull"},{"key":"R53-5-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13651500500526235","article-title":"Effect of hormone replacement therapy on cognitive function in women with chronic schizophrenia.","volume":"10","author":"Ko","year":"2006","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R54-5-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/gme.0b013e3181bd54df","article-title":"Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial.","volume":"17","author":"Jacobsen","year":"2010","journal-title":"Menopause"},{"key":"R55-5-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.yhbeh.2010.09.003","article-title":"Increased memory load-related frontal activation after estradiol treatment in postmenopausal women.","volume":"58","author":"Dumas","year":"2010","journal-title":"Horm Behav"},{"key":"R56-5-20210206","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/JGP.0b013e3181ff678a","article-title":"Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17-estradiol versus conjugated equine estrogens.","volume":"19","author":"Wroolie","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"R57-5-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JGP.0b013e3181beaaf4","article-title":"Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.","volume":"18","author":"Valen-Sendstad","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"R58-5-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.psyneuen.2004.08.007","article-title":"Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.","volume":"30","author":"Schiff","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"R59-5-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.06.024","article-title":"Neuroactive steroids: focus on human brain.","volume":"191","author":"Melcangi","year":"2011","journal-title":"Neuroscience"},{"key":"R60-5-20210206","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3949\/ccjm.74.5.341","article-title":"Anabolic steroid abuse: psychiatric and physical costs.","volume":"74","author":"Talih","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"R61-5-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yfrne.2008.11.002","article-title":"Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).","volume":"30","author":"Maninger","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"R62-5-20210206","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2011.04.017","article-title":"The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia.","volume":"191","author":"Ritsner","year":"2011","journal-title":"Neuroscience"},{"key":"R63-5-20210206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence.","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"key":"R64-5-20210206","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","article-title":"Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.","volume":"68","author":"Feifel","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R65-5-20210206","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1020076426727","article-title":"Selective estrogen receptor modulators.","volume":"3","author":"Bryant","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"issue":"Suppl 1","key":"R66-5-20210206","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.psyneuen.2009.04.012","article-title":"Neuroprotective actions of selective estrogen receptor modulators.","volume":"34","author":"DonCarlos","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R67-5-20210206","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09540261003702355","article-title":"Special issues in managing long-term mental illness in women.","volume":"22","author":"Kulkarni","year":"2010","journal-title":"Int Rev Psychiatry"},{"key":"R68-5-20210206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.schres.2004.07.016","article-title":"Cumulative exposure to estrogen and psychosis: a peak bone mass, case-control study in first-episode psychosis.","volume":"73","author":"Maric","year":"2005","journal-title":"Schizophr Res"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/YCO.0b013e328350360e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:01Z","timestamp":1786047961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001504-201203000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0b013e328350360e","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}